• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (105)
  • (96)
  • (48)

Deal Type

  • (297)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co acts as Sole Financial Advisor to eSmart Systems on its EUR 30m capital raise led by Tilt Capital, with strategic partner Quanta Services and existing investors

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on ONWARD Medical’s EUR 50m Follow-On Offering, anchored for EUR 22.5m by a Cornerstone Investment from Ottobock

Bryan, Garnier & Co acts as Sole Financial Advisor to Cyber Guru and its shareholders on an investment round led by Riverside Acceleration Capital

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Timma, a leading Nordic software provider to hair and beauty professionals, on its sale to EG

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Halon, a leading email infrastructure software provider, on its sale to Intera Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to NetGuardians and its shareholders on the investment from Summa Equity

Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ SEK 300 million Follow-On Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to Groupe Technic Assistance on the contemplated sale of the Company to NEO2, supported by CAPZA and Turenne Groupe

Bryan, Garnier & Co acts as Sole Financial Advisor to Isoskèle, subsidiary of La Poste Groupe, on the contemplated acquisition of LineUP7, a leading data marketing agency

Bryan, Garnier & Co acts as Sole Secondary Advisor to a group of historical shareholders in Back Market on the secondary sale of their shares to Noteus Partners and AFIR

Bryan, Garnier & Co acts as Sole Financial Advisor to Abenex and the Management of EDL on a secondary LBO led by Dentressangle Capital

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Valneva’s EUR 61.2m Follow-On Offering

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 50

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
  • Clément Genelot, les financements se rouvrent enfin en Europe
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }